Period:
Draw Mode:
| Volume | 159,480 |
|
|||||
| News | - | ||||||
| Day High | 31.55 | Low High |
|||||
| Day Low | 30.1501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Beam Therapeutics Inc | BEAM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.57 | -1.84% | 30.45 | 10:29:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 31.50 | 30.1501 | 31.55 | 31.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,433 | 159,480 | $ 30.84 | $ 4,918,731 | - | 27.77 - 73.27 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:29:33 | 1 | $ 30.46 | USD |
Beam Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.20B | 72.40M | 63.15M | $ 60.92M | $ - | -4.13 | -8.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -227.64k | 1.70% |
Beam Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BEAM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.05 | 31.79 | 29.59 | 30.51 | 923,948 | -0.60 | -1.93% |
| 1 Month | 38.00 | 40.00 | 29.59 | 34.24 | 1,116,303 | -7.55 | -19.87% |
| 3 Months | 40.49 | 50.74 | 29.59 | 39.11 | 925,364 | -10.04 | -24.8% |
| 6 Months | 47.19 | 54.30 | 29.59 | 41.81 | 870,653 | -16.74 | -35.47% |
| 1 Year | 61.61 | 73.27 | 27.77 | 45.40 | 1,076,679 | -31.16 | -50.58% |
| 3 Years | 18.00 | 138.5219 | 14.80 | 61.03 | 847,797 | 12.45 | 69.17% |
| 5 Years | 19.19 | 138.5219 | 13.00 | 60.11 | 829,447 | 11.26 | 58.68% |
Beam Therapeutics Description
| Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. |